Edited By: C. W. Howden, R. Loomba, G. M. Dusheiko, A. C. Ford, R. B. Gearry, P. R. Gibson, G. M. Hirschfield, G. L-H. Wong, C. H. Seow, S. Subramanian, V. W-S. Wong and S. C. Shah
Journal list menu
Alimentary Pharmacology & Therapeutics is a global pharmacology journal concerned with the effects of drugs on the human gastrointestinal and hepato-biliary systems, publishing a diverse range of topics in the space often with immediate clinical impact to our readership.
We are interested in therapies and diagnostics, including all aspects of translation from bench to bedside and clinical trials.
Thirteen good reasons why authors prefer AP&T
✮2022 Impact Factor is 7.633, ranking AP&T 17/93 for journals in Gastroenterology & Hepatology.
✮Quick decisions: Submission to first decision in 12 days on average in 2022.
✮FREE submission.
✮FREE colour figures.
✮No overall word count limit for original articles.
✮Fast publication: only 7 weeks from acceptance to publication in an online issue, with its final and full citation.
✮Possible Transfer Option to GastroHep if paper rejected by AP&T.
✮Follow @APandT for daily links to the latest articles.
✮Google Scholar: AP&T now ranks at number 11 in Google Scholar’s list of top publications in Gastroenterology & Hepatology.
✮AP&T's 2021 SCImago SJR is 2.786, ranking it 8/157 in Gastroenterology and 9/74 in Hepatology.
✮FREE PDF off-prints for all authors.
✮Open Access publishing: after full peer-review, authors can choose to publish open access.
✮'Early View': The final corrected proofs of each article are published 16-24 days after acceptance, and listed by PubMed only days later.
Most read articles
AP&T Podcasts
Articles
Letter: Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
- 1242-1242
- 20 November 2023
LINKED CONTENT
This article is linked to Kochhar et al papers. To view these articles, visit https://doi.org/10.1111/apt.17570 and https://doi.org/10.1111/apt.17750
Letter: The importance of histological assessment—a further stride in STRIDE
- 1244-1245
- 20 November 2023
LINKED CONTENT
This article is linked to Dignass et al papers. To view these articles, visit https://doi.org/10.1111/apt.17622 and https://doi.org/10.1111/apt.17763
Editorial: On-demand vonoprazan for NERD—when should it be ‘demanded’?
- 1230-1230
- 20 November 2023
LINKED CONTENT
This article is linked to Fass et al papers. To view these articles, visit https://doi.org/10.1111/apt.17728 and https://doi.org/10.1111/apt.17766
Editorial: Assessing advanced fibrosis in metabolic-associated steatotic liver disease—The MAFLD fibrosis score
- 1234-1235
- 20 November 2023
LINKED CONTENT
This article is linked to Cheung et al papers. To view these articles, visit https://doi.org/10.1111/apt.17722 and https://doi.org/10.1111/apt.17774
Letter: Abdominal pain in inflammatory bowel disease patients in remission—A look beyond psychosocial factors
- 1248-1249
- 20 November 2023
LINKED CONTENT
This article is linked to Janssen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17718 and https://doi.org/10.1111/apt.17775
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
- 274-285
- 30 May 2011
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress
- 395-402
- 2 October 2003
Review article: gastrointestinal features in COVID‐19 and the possibility of faecal transmission
- 843-851
- 29 March 2020
Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection
- 868-876
- 12 February 2018
Abstract
Linked Content
This article is linked to Zamani et al and Tsipotis and Leontiadis papers. To view these articles visit https://doi.org/10.1111/apt.14609 and https://doi.org/10.1111/apt.14618.
Recent issues
Latest news
Sign up for email alerts
Tools
In the Spotlight:
Colin Howden, Co-Editor
“Papers are selected due to high-quality and high clinical importance to our predominately clinical readership…we have a lot of contact with key opinion leaders around the world.”
Colin Howden, Co-Editor-in-Chief
Discover how Alimentary Pharmacology & Therapeutics is providing solutions to some of the biggest questions in the field, along with our aspirations for the future in this short video.
|
|
.png)
@APandT
@APandT provides a daily link to a new article, published by AP&T.
News
Médecins Sans Frontières
In 2022, AP&T’s 890 Reviewers donated £26,300 to Médecins Sans Frontières (USD 31,568 or EURO 29,866 at 03.01.23 exchange rates) in place of receiving any personal fees.
For the full list of AP&T's reviewers click here.
More from this journal
- News
- Video Abstracts
- Virtual Issue: Celebrating 50 Volumes of AP&T
- Top Downloads for the previous two months
- Readers' Choice Top Downloaded Articles 2022
- Authors' Choice: Top Citations 2021
- FREE: Editor's Food Allergy & Intolerance Collection
- FREE: Editor's Hepatology Collection
- FREE: Editor's Inflammatory Bowel Disease Collection
- FREE: Editor's Oesophagus Collection
- FREE: Editor's Motility and Functional Collection
- FREE: CLASSIC PAPERS with high downloads
- Podcasts
- Editors Declaration of Interests
- Wiley’s Gastroenterology Collection